Speech-Language Pathologists in Beaumont, CA Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Mrs. Sierra Shannon Carrier, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 Evan Way, Beaumont, CA 92223 Phone: 714-595-6446

Beyond A-z Speech Therapy Services, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1326 Melstone St, Beaumont, CA 92223 Phone: 951-755-4500

Mr. Mukunthan Subramani Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1664 Lakeside Ave, Beaumont, CA 92223 Phone: 323-423-7187

Julie Ana M Chua, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1326 Melstone St, Beaumont, CA 92223 Phone: 951-755-4500

News Archive

Older Aussies busy in bed

A global study on the sexual attitudes and behaviours of 27,500 men and women from 29 countries has revealed a few surprises.

Repro-Med Systems net revenue increases 30% for fiscal year ending February 28, 2011

Repro-Med Systems, Inc., dba RMS Medical Products, today announced unaudited financial results for its fiscal year ended February 28, 2011, showing increases in both domestic and international sales.

Prenatal POP exposure may increase the risk of metabolic disorders in adolescence

Exposure before birth to persistent organic pollutants (POPs)- organochlorine pesticides, industrial chemicals, etc.-may increase the risk in adolescence of metabolic disorders, such as obesity and high blood pressure.

CHCs and primary care providers will become America's obesity 'first responders'

Community health centers (CHCs) and primary care providers working in other settings will increasingly become America's obesity "first responders," needed to provide weight-related health services as the nation continues to implement the Affordable Care Act.

Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease

Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacteremia (bacteria in the blood).

Read more Medical News

› Verified 6 days ago